INVO Fertility (IVF) Return on Capital Employed (2012 - 2026)
INVO Fertility (IVF) posted quarterly Return on Capital Employed of 46.11% for Q1 2026, up 3338.0% year-over-year from 1.34% in Q1 2025, and up 51.2% quarter-over-quarter from 94.49% in Q3 2025.
INVO Fertility (IVF) Return on Capital Employed (2012 - 2026) Analysis & Trends
INVO Fertility (IVF) has reported Return on Capital Employed for 15 consecutive years, with 46.11% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Capital Employed rose 3338.0% year-over-year to 46.11%; the TTM figure through Mar 2026 stood at 46.11% (up 3338.0% YoY), while the FY2024 annual figure was 55.84%, up 16211.0% from the prior year.
- Return on Capital Employed rose to 46.11% in Q1 2026 per IVF's latest filing, from 94.49% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 460.17% in Q2 2023 and bottomed at 1635.9% in Q4 2022.
- Historically, Return on Capital Employed has averaged 119.06% across 5 years, with a median of 86.99% in 2025.
- Annual changes were most pronounced in 2022 — Return on Capital Employed slumped 156820 bps — and 2023, when it jumped 156663 bps.
- INVO Fertility's Return on Capital Employed stood at 1635.9% in 2022, then soared by 96 bps to 69.26% in 2023, then slumped by 120 bps to 152.72% in 2024, then jumped by 38 bps to 94.49% in 2025, then soared by 51 bps to 46.11% in 2026.
- Business Quant data shows IVF's Return on Capital Employed at 46.11% in Q1 2026, 94.49% in Q3 2025, and 354.8% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 12.08% |
| 10 | INVO Fertility | 2.43 Mn | 2.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.11% |
| Sep 30, 2025 | -94.49% |
| Jun 30, 2025 | -354.80% |
| Mar 31, 2025 | -79.50% |
| Dec 31, 2024 | -152.72% |
| Sep 30, 2024 | 71.66% |
| Jun 30, 2024 | 262.50% |
| Mar 31, 2024 | -96.42% |
| Dec 31, 2023 | -69.26% |
| Sep 30, 2023 | -126.66% |
| Jun 30, 2023 | 460.17% |
| Mar 31, 2023 | 367.69% |
| Dec 31, 2022 | -1,635.90% |
| Sep 30, 2022 | -209.10% |
| Jun 30, 2022 | -122.79% |
| Mar 31, 2022 | -79.24% |
| Dec 31, 2021 | -67.69% |
| Sep 30, 2021 | -114.41% |
| Jun 30, 2021 | -79.32% |
| Mar 31, 2021 | -65.20% |